» Articles » PMID: 33467995

Self-clearance of Infection: Implications for Lifetime Risk and Population At-risk of Tuberculosis Disease

Overview
Journal Proc Biol Sci
Specialty Biology
Date 2021 Jan 20
PMID 33467995
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

: it is widely assumed that individuals with () infection remain at lifelong risk of tuberculosis (TB) disease. However, there is substantial evidence that self-clearance of infection can occur. We infer a curve of self-clearance by time since infection and explore its implications for TB epidemiology. : data for self-clearance were inferred using post-mortem and tuberculin-skin-test reversion studies. A cohort model allowing for self-clearance was fitted in a Bayesian framework before estimating the lifetime risk of TB disease and the population infected with in India, China and Japan in 2019. We estimated that 24.4% (17.8-32.6%, 95% uncertainty interval (UI)) of individuals self-clear within 10 years of infection, and 73.1% (64.6-81.7%) over a lifetime. The lifetime risk of TB disease was 17.0% (10.9-22.5%), compared to 12.6% (10.1-15.0%) assuming lifelong infection. The population at risk of TB disease in India, China and Japan was 35-80% (95% UI) smaller in the self-clearance scenario. : the population with a viable infection may be markedly smaller than generally assumed, with such individuals at greater risk of TB disease. The ability to identify these individuals could dramatically improve the targeting of preventive programmes and inform TB vaccine development, bringing TB elimination within reach of feasibility.

Citing Articles

Epidemiology of Latent Tuberculosis in Moroccan Healthcare Workers: Prevalence Patterns and Predisposing Factors.

Boucaid A, Zegmout A, Bhairis M, Amraoui M, Laaraje A, Hassane Kabiri E Cureus. 2025; 16(12):e75740.

PMID: 39816277 PMC: 11732615. DOI: 10.7759/cureus.75740.


Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia.

Setiabudiawan T, Apriani L, Verrall A, Utami F, Schneider M, Indrati A Nat Commun. 2025; 16(1):309.

PMID: 39747050 PMC: 11695729. DOI: 10.1038/s41467-024-55501-6.


Tuberculosis morbidity and mortality during the COVID-19 pandemic: a life-threatening complex challenge.

Al Khatib A, Hassanein S, Almari M, Koubar M, Fakhreddine S Front Cell Infect Microbiol. 2024; 14:1423081.

PMID: 39411323 PMC: 11473592. DOI: 10.3389/fcimb.2024.1423081.


Role of Type I Interferons during and HIV Infections.

Anes E, Azevedo-Pereira J, Pires D Biomolecules. 2024; 14(7).

PMID: 39062562 PMC: 11275242. DOI: 10.3390/biom14070848.


Epidemiology and antimicrobial resistance of spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data.

Thomsen J, Abdulrazzaq N, Nyasulu P, Al Hosani F, Habous M, Weber S Front Public Health. 2024; 12:1244353.

PMID: 38947352 PMC: 11211529. DOI: 10.3389/fpubh.2024.1244353.


References
1.
Menzies N, Wolf E, Connors D, Bellerose M, Sbarra A, Cohen T . Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis. 2018; 18(8):e228-e238. PMC: 6070419. DOI: 10.1016/S1473-3099(18)30134-8. View

2.
Esmail H, Barry 3rd C, Wilkinson R . Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discov Today. 2011; 17(9-10):514-21. PMC: 3443737. DOI: 10.1016/j.drudis.2011.12.013. View

3.
CANETTI G, Sutherland I, Svandova E . Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis. Bull Int Union Tuberc. 1972; 47:116-34. View

4.
Vynnycky E, Fine P . The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997; 119(2):183-201. PMC: 2808840. DOI: 10.1017/s0950268897007917. View

5.
Andrews J, Noubary F, Walensky R, Cerda R, Losina E, Horsburgh C . Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012; 54(6):784-91. PMC: 3284215. DOI: 10.1093/cid/cir951. View